13F filer · CIK 1214717 ↗
Geode Capital Management, LLC
You are looking at Q1 2019. See the latest, Q2 2026 →
Reported value
$385.96B
−40% on the quarter before
Positions
4,127
141 new · 159 sold out
Top 10
17.2%
of the value
Est. gain
+$45.07B
on stocks held all quarter
Est. return
+13.3%
on those stocks since Q4 2018
Positions as of Mar 31, 2019, from Geode Capital Management, LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 29% of the reported value, each sized by its share, colored by what the fund did with it since Q4 2018. Striped tiles are options.
Largest buys
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Fox Corp - Class A~$174.6MNew · 0.0% → 0.0%+4,763,740 shares
- Apartment Invt & Mgmt Co -A~$147.1MNew · 0.0% → 0.0%+2,928,166 shares
- Steris Plc~$109.9MNew · 0.0% → 0.0%+858,488 shares
- Fox Corp - Class B~$80.7MNew · 0.0% → 0.0%+2,252,828 shares
- Elanco Animal Health Inc~$66.0MAdded · 0.0% → 0.0%+2,060,954 shares
- Covetrus Inc~$28.8MNew · 0.0% → 0.0%+905,128 shares
- Element Solutions Inc~$23.8MNew · 0.0% → 0.0%+2,352,599 shares
- Wabtec Corp~$22.9MAdded · 0.0% → 0.0%+311,825 shares
- Ilmn 0 06/15/19~$18.4MNew · 0.0% → 0.0%+15,000,000 shares
- Zto Express Cayman Inc-ADR~$18.3MNew · 0.0% → 0.0%+1,008,150 shares
Largest sells
Since Q4 2018, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Microsoft~$11.62BCut · 3.1% → 3.1%−98,687,037 shares
- Apple~$10.58BCut · 2.8% → 3.0%−55,765,012 shares
- Amazon~$8.48BCut · 2.3% → 2.5%−4,773,712 shares
- Meta~$5.42BCut · 1.3% → 1.3%−32,581,583 shares
- Johnson & Johnson~$5.15BCut · 1.4% → 1.3%−36,889,416 shares
- Alphabet~$4.57BCut · 1.3% → 1.2%−3,902,634 shares
- Alphabet~$4.29BCut · 1.2% → 1.2%−3,648,572 shares
- Berkshire Hathaway Inc-Cl B~$4.25BCut · 1.5% → 1.3%−21,211,720 shares
- Jpmorgan Chase & Co~$3.93BCut · 1.2% → 1.1%−38,849,636 shares
- Exxon Mobil Corp~$3.83BCut · 1.1% → 1.2%−47,531,183 shares
Holdings
As of Mar 31, 2019. Changes are in shares against Dec 31, 2018, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −49% · price +16.1% | 3.1% | $11.95B | +$1.66B | ||||||||
| AppleCOM · shares −48% · price +20.4% | 3.0% | $11.58B | +$1.96B | ||||||||
| AmazonCOM · shares −47% · price +18.6% | 2.5% | $9.51B | +$1.49B | ||||||||
| MetaCL A · shares −51% · price +27.1% | 1.3% | $5.15B | +$1.10B | ||||||||
| Berkshire Hathaway Inc-Cl BCL B NEW · shares −45% · price −1.6% | 1.3% | $5.10B | −$83.3M | ||||||||
| Johnson & JohnsonCOM · shares −51% · price +8.3% | 1.3% | $5.00B | +$384.1M | ||||||||
| AlphabetCAP STK CL A · shares −48% · price +12.6% | 1.2% | $4.70B | +$527.0M | ||||||||
| AlphabetCAP STK CL C · shares −49% · price +13.3% | 1.2% | $4.67B | +$547.5M | ||||||||
| Exxon Mobil CorpCOM · shares −46% · price +18.5% | 1.2% | $4.59B | +$716.5M | ||||||||
| Jpmorgan Chase & CoCOM · shares −48% · price +3.7% | 1.1% | $4.28B | +$152.9M | ||||||||
| Visa Inc.COM CL A · shares −47% · price +18.4% | 1.0% | $3.89B | +$603.6M | ||||||||
| Procter & Gamble Co/TheCOM · shares −49% · price +13.2% | 0.95% | $3.68B | +$428.8M | ||||||||
| Pfizer IncCOM · shares −44% · price −2.7% | 0.92% | $3.56B | −$98.3M | ||||||||
| IntelCOM · shares −51% · price +14.4% | 0.90% | $3.47B | +$437.1M | ||||||||
| Verizon Communications IncCOM · shares −47% · price +5.2% | 0.88% | $3.41B | +$168.1M | ||||||||
| CiscoCOM · shares −52% · price +24.6% | 0.86% | $3.33B | +$658.2M | ||||||||
| Bank Of America CorpCOM · shares −49% · price +12.0% | 0.83% | $3.21B | +$343.8M | ||||||||
| Merck & Co. Inc.COM · shares −44% · price +8.9% | 0.81% | $3.14B | +$256.0M | ||||||||
| Chevron CorpCOM · shares −48% · price +13.2% | 0.81% | $3.12B | +$365.1M | ||||||||
| AT&TCOM · shares −47% · price +9.9% | 0.80% | $3.11B | +$279.2M | ||||||||
| Unitedhealth Group IncCOM · shares −47% · price −0.7% | 0.79% | $3.06B | −$22.9M | ||||||||
| MastercardCL A · shares −49% · price +24.8% | 0.77% | $2.98B | +$593.1M | ||||||||
| Home Depot IncCOM · shares −42% · price +11.7% | 0.77% | $2.97B | +$311.4M | ||||||||
| Wells Fargo & CoCOM · shares −48% · price +4.9% | 0.67% | $2.57B | +$119.4M | ||||||||
| Comcast Corp-Class ACL A · shares −50% · price +17.4% | 0.66% | $2.56B | +$379.8M | ||||||||
| Total · 4,127 positions | 100% | $385.96B | +$45.07B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2018 to Q1 2019: 3,943 stocks held throughout, up $45.07B (+13.3%).
- Apple+$1.96B+20%
- Microsoft+$1.66B+16%
- Amazon+$1.49B+19%
- Meta+$1.10B+27%
- Exxon Mobil Corp+$716.5M+19%
- Cigna Corp−$147.1M−15%
- Biogen Inc−$195.9M−21%
- Cvs Health Corp−$203.1M−18%
- Abbvie Inc−$247.2M−13%
- Centene Corp−$358.2M−54%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 73 splits read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $1.88T+17% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $1.61T−1% | SEC ↗ |
| Q4 2025 | Feb 9, 2026 | $1.62T+3% | SEC ↗ |
| Q3 2025 | Nov 12, 2025 | $1.57T+10% | SEC ↗ |
| Q2 2025 | Aug 8, 2025 | $1.43T+12% | SEC ↗ |
| Q1 2025 | May 13, 2025 | $1.27T−1% | SEC ↗ |
| Q4 2024 | Feb 12, 2025 | $1.29T+5% | SEC ↗ |
| Q3 2024 | Nov 12, 2024 | $1.23T+8% | SEC ↗ |
| Q2 2024 | Aug 9, 2024 | $1.14T+5% | SEC ↗ |
| Q1 2024 | May 13, 2024 | $1.08T+13% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $955.85B+14% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $839.58B−1% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $850.99B+11% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $770.08B+8% | SEC ↗ |
| Q4 2022 | Feb 13, 2023 | $712.57B+8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $659.25B−3% | SEC ↗ |
| Q2 2022 | Aug 12, 2022 | $682.64B−15% | SEC ↗ |
| Q1 2022 | May 13, 2022 | $801.12B−4% | SEC ↗ |
| Q4 2021 | Feb 11, 2022 | $830.26B+12% | SEC ↗ |
| Q3 2021 | Nov 12, 2021 | $742.82B+2% | SEC ↗ |
| Q2 2021 | Aug 13, 2021 | $725.80B+11% | SEC ↗ |
| Q1 2021 | May 12, 2021 | $653.80B+10% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $595.80B+17% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $510.36B+9% | SEC ↗ |
| Q2 2020 | Aug 13, 2020 | $467.44B+22% | SEC ↗ |
| Q1 2020 | May 14, 2020 | $383.70B−60% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 (amended) | $956.78B+123% | SEC ↗ |
| Q3 2019 | Nov 12, 2019 | $428.50B+4% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $413.26B+7% | SEC ↗ |
| Q1 2019 | May 14, 2019 | $385.96B−40% | SEC ↗ |
| Q4 2018 | Feb 13, 2019 (amended) | $646.86B+82% | SEC ↗ |
| Q3 2018 | Nov 13, 2018 | $354.88B+9% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $325.29B+6% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $306.93B+4% | SEC ↗ |
| Q4 2017 | Feb 13, 2018 | $294.47B+9% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $270.92B+7% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $254.31B+4% | SEC ↗ |
| Q1 2017 | Jun 21, 2017 (amended) | $243.78B+13% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $215.04B+8% | SEC ↗ |
| Q3 2016 | Nov 10, 2016 | $198.58B+8% | SEC ↗ |
| Q2 2016 | Aug 12, 2016 | $183.87B−2% | SEC ↗ |
| Q1 2016 | May 13, 2016 | $188.44B | SEC ↗ |